PMID: 11927283Apr 3, 2002Paper

The ErbB receptor family: a therapeutic target for cancer

Trends in Molecular Medicine
Johann S de Bono, Eric K Rowinsky

Abstract

This article reviews the current state of efforts targeting the ErbB family of tyrosine kinase receptors in cancer therapy. In particular, preliminary results will be discussed of studies of the first generation of therapeutics to enter clinical evaluation in malignant diseases. Results of recently conducted clinical studies with ZD1839 (Iressa), OSI-774 (Tarceva), Cetuximab (IMC-C225) and trastuzumab (Herceptin) and several other compounds are presented. Potential advantages and disadvantages of these different therapeutic modalities, as well as future challenges of evaluating ErbB-targeted agents in the clinic, are presented.

References

Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Aug 5, 1999·Journal of the National Cancer Institute·K A GelmonP Workman
Nov 1, 2000·Cell·J Schlessinger
Mar 20, 2001·Critical Reviews in Oncology/hematology·X D YangC G Davis
Jun 28, 2001·Oncogene·J Mendelsohn, J Baselga
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Baselga
Nov 14, 2001·Seminars in Oncology·J BaselgaJ Arribas

❮ Previous
Next ❯

Citations

Sep 26, 2006·Pathology Oncology Research : POR·Tamás LôrinczMiklós Szendrôi
Mar 27, 2012·Analytical and Bioanalytical Chemistry·Sihai HanWei Jin
Oct 12, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Agnieszka DreierJoachim Weis
Apr 20, 2004·Critical Reviews in Oncology/hematology·Amar BennasrounePierre Hubert
Mar 17, 2004·Cancer Treatment Reviews·Juan Angel Fresno VaraManuel González-Barón
May 18, 2004·Cancer Treatment Reviews·John D ChesterAndrew S Protheroe
Mar 22, 2003·Experimental Cell Research·Thomas HolbroNancy E Hynes
Jul 10, 2003·Critical Reviews in Oncology/hematology·Cora N Sternberg, Nicholas J Vogelzang
May 6, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Moulay A Alaoui-Jamali, He Qiang
Nov 1, 2003·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·J Cassidy, H Hochster
Oct 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Andrzej StepulakChrysanthy Ikonomidou
Dec 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Terrance G JohnsAndrew M Scott
Jun 30, 2009·The Journal of Biological Chemistry·Satoshi KawanoYoshimi Takai
Jun 24, 2004·Journal of Gastroenterology and Hepatology·Harikleia Kalekou, Dimosthenis Miliaras
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Thomas Holbro, Nancy E Hynes
Jun 19, 2002·The Journal of Clinical Investigation·Rosemary J Akhurst
Jun 10, 2003·Breast Cancer Research : BCR·Johann S de BonoEric K Rowinsky
Nov 19, 2009·Drug Design, Development and Therapy·Akito NatsumeMitsuo Satoh
Mar 8, 2014·Pharmaceuticals·Wiebke SihverHans-Jürgen Pietzsch
May 16, 2014·Molecular Therapy. Nucleic Acids·David V LiuK Dane Wittrup
Dec 17, 2008·Women's Health·Jose RussoTerumi Kohwi-Shigematsu
Jan 14, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masakazu ToiShigehira Saji
Dec 31, 2015·European Journal of Medicinal Chemistry·Jin ZhangLiang Ouyang
Dec 15, 2015·Bioorganic & Medicinal Chemistry Letters·Xiang-Xiang TaoHai-Liang Zhu
Dec 17, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hua ShenYong-Qian Shu
Dec 15, 2004·Biophysical Journal·Péter BagossiJózsef Tözsér
Feb 14, 2006·The Journal of Urology·Delphine Amsellem-OuazanaRosette Lidereau
Nov 25, 2003·Cancer Investigation·Akio Inui
May 15, 2009·Cancer Investigation·Ingrid LaurendeauIrene Szijan
Oct 20, 2006·Expert Opinion on Biological Therapy·Mitsuo SatohKenya Shitara
Jun 5, 2003·Expert Opinion on Investigational Drugs·Rita NahtaFrancisco J Esteva
Jul 30, 2005·Expert Opinion on Biological Therapy·Barbara Burtness
Aug 20, 2003·The Journal of Clinical Investigation·Heather B AdkinsMichele Sanicola
May 7, 2013·Bioengineered·Maria-Cristina S Pranchevicius, Thiessa R Vieira
Jan 13, 2010·MAbs·Naoko Yamane-Ohnuki, Mitsuo Satoh
Dec 18, 2007·Neoplasia : an International Journal for Oncology Research·Rushika M PereraAndrew M Scott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Anticancer Therapy
Antonio J Grillo-López
The Breast Journal
Charles L Vogel, Sandra X Franco
Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character
C J MarshallB Ozanne
Methods in Molecular Biology
Nora Hornig, Aline Färber-Schwarz
© 2022 Meta ULC. All rights reserved